The effect of folinic acid supplementation on homocysteine concentrations in newborns

European Journal of Clinical Nutrition

Volumn 64, Issue 11, 2010, Pages 1266-1271

  Hogeveen, M ^a   Den Heijer, M ^a   Schonbeck, Y ^a   Ijland, M ^a   Van Oppenraaij, D ^a   Gunnewiek, J K ^a   Blom, H J ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

cerebrovascular accident; folic acid; folinic acid; homocysteine; newborns; stroke

Indexed keywords

COBALAMIN; CREATININE; FOLIC ACID; FOLINIC ACID; HOMOCYSTEINE; PLACEBO;

AMINO ACID BLOOD LEVEL; ARTICLE; BIRTH WEIGHT; CARBON METABOLISM; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; FEMALE; FOLIC ACID BLOOD LEVEL; GESTATIONAL AGE; HUMAN; INTERVENTION STUDY; MALE; NEWBORN; NEWBORN INTENSIVE CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT DURATION;

CEREBROVASCULAR DISORDERS; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFANT, PREMATURE; LEUCOVORIN; MALE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 78149281844     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2010.155     Document Type: Article

References (39)

1. Akar N, Akar E, Ozel D, Deda G, Sipahi T (2001). Common mutations at the homocysteine metabolism pathway and pediatric stroke. Thromb Res 102, 115-120.
2. Bjorke Monsen AL, Ueland PM (2003). Homocysteine and methyl-malonic acid in diagnosis and risk assessment from infancy to adolescence. Am J Clin Nutr 78, 7-21.
3. Bjorke Monsen AL, Ueland PM, Vollset SE, Guttormsen AB, Markestad T, Solheim E et al. (2001). Determinants of cobalamin status in newborns. Pediatrics 108, 624-630.
4. Bjorke-Monsen AL, Torsvik I, Saetran H, Markestad T, Ueland PM (2008). Common metabolic profile in infants indicating impaired cobalamin status responds to cobalamin supplementation. Pediatrics 122, 83-91.
5. Brattstrom LE, Israelsson B, Jeppsson JO, Hultberg BL (1988). Folic acid - an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest 48, 215-221.
6. Buccianti G, Bamonti CF, Patrosso C, Corghi E, Novembrino C, Baragetti I et al. (2001). Reduction of the homocysteine plasma concentration by intravenously administered folinic acid and vitamin B(12) in uraemic patients on maintenance haemodialysis. Am J Nephrol 21, 294-299.
7. Couto FD, Moreira LM, Dos Santos DB, Reis MG, Goncalves MS (2007). Folate, vitamin B12 and total homocysteine levels in neonates from Brazil. Eur J Clin Nutr 61, 382-386.
8. den Heijer M, Rosendaal FR, Blom HJ, Gerrits WB, Bos GM (1998). Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 80, 874-877.
9. Ducloux D, Aboubakr A, Motte G, Toubin G, Fournier V, Chalopin JM et al. (2002). Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12. Nephrol Dial Transplant 17, 865-870.
10. Fokkema MR, Woltil HA, van Beusekom CM, Schaafsma A, Dijck-Brouwer DA, Muskiet FA (2002). Plasma total homocysteine increases from day 20 to 40 in breastfed but not formula-fed low-birthweight infants. Acta Paediatr 91, 507-511.
11. Fuller NJ, Bates CJ, Cole TJ, Lucas A (1992). Plasma folate levels in preterm infants, with and without a 1mg daily folate supplement. Eur J Pediatr 151, 48-50.
12. Gellekink H, den Heijer M, Heil SG, Blom HJ (2005). Genetic determinants of plasma total homocysteine. Semin Vasc Med 5, 98-109.
13. Grabowski EF, Buonanno FS, Krishnamoorthy K (2007). Prothrom-botic risk factors in the evaluation and management of perinatal stroke. Semin Perinatol 31, 243-249.
14. Guerra-Shinohara EM, Paiva AA, Rondo PH, Yamasaki K, Terzi CA, D'Almeida V (2002). Relationship between total homocysteine and folate levels in pregnant women and their newborn babies according to maternal serum levels of vitamin B12. BJOG 109, 784-791.
15. Hauser AC, Hagen W, Rehak PH, Buchmayer H, Fodinger M, Papagiannopoulos M et al. (2001). Efficacy of folinic versus folic acid for the correction of hyperhomocysteinemia in hemodialysis patients. Am J Kidney Dis 37, 758-765.
16. Herrmann W, Herrmann M, Obeid R (2007). Hyperhomocysteinaemia: a critical review of old and new aspects. Curr Drug Metab 8, 17-31.
17. Hogeveen M, Blom HJ, Van Amerongen M, Boogmans B, van Beynum I, van de Bor M (2002). Hyperhomocysteinemia as risk factor for ischemic and hemorrhagic stroke in newborn infants. J Pediatr 141, 429-431.
18. Homocysteine Lowering Trialists' Collaboration (2000). Lowering blood homocysteine with folic acid-based supplements: meta-analysis of randomised trials. Indian Heart J 52, S59-S64.
19. Homocysteine Lowering Trialists' Collaboration (2005). Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 82, 806-812.
20. Hongsprabhas P, Saboohi F, Aranda JV, Bardin CL, Kovacs LB, Papageorgiou AN et al. (1999). Plasma homocysteine concentrations of preterm infants. Biol Neonate 76, 65-71.
21. Jyothi S, Misra I, Morris G, Benton A, Griffin D, Allen S (2007). Red cell folate and plasma homocysteine in preterm infants. Neonatology 92, 264-268.
22. Karademir F, Suleymanoglu S, Ersen A, Aydinoz S, Gultepe M, Meral C et al. (2007). Vitamin B12, folate, homocysteine and urinary methylmalonic acid levels in infants. J Int Med Res 35, 384-388.
23. Minet JC, Bisse E, Aebischer CP, Beil A, Wieland H, Lutschg J (2000). Assessment of vitamin B-12, folate, and vitamin B-6 status and relation to sulfur amino acid metabolism in neonates. Am J Clin Nutr 72, 751-757.
24. Molloy AM, Mills JL, McPartlin J, Kirke PN, Scott JM, Daly S (2002). Maternal and fetal plasma homocysteine concentrations at birth: the influence of folate, vitamin B12, and the 5,10-methylenete-trahydrofolate reductase 677C->T variant. Am J Obstet Gynecol 186, 499-503.
25. Raju TN, Nelson KB, Ferriero D, Lynch JK (2007). Ischemic perinatal stroke: summary of a workshop sponsored by the National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke. Pediatrics 120, 609-616.
26. Refsum H, Grindflek AW, Ueland PM, Fredriksen A, Meyer K, Ulvik A et al. (2004). Screening for serum total homocysteine in newborn children. Clin Chem 50, 1769-1784.
27. Schulpis K, Spiropoulos A, Gavrili S, Karikas G, Grigori C, Vlachos G et al. (2004). Maternal - neonatal folate and vitamin B12 serum concentrations in Greeks and in Albanian immigrants. J Hum Nutr Diet 17, 443-448.
28. Sirachainan N, Tapanapruksakul P, Visudtibhan A, Chuansumrit A, Cheeramakara C, Atamasirikul K et al. (2006). Homocysteine, MTHFR C677 T, vitamin B12, and folate levels in Thai children with ischemic stroke: a case-control study. J Pediatr Hematol Oncol 28, 803-808.
29. te Poele-Pothoff MT, van den Berg M, Franken DG, Boers GH, Jakobs C, de Kroon I et al. (1995). Three different methods for the determination of total homocysteine in plasma. Ann Clin Biochem 32 (Part 2), 218-220.
30. Touam M, Zingraff J, Jungers P, Chadefaux-Vekemans B, Drueke T, Massy ZA (1999). Effective correction of hyperhomocysteinemia in hemodialysis patients by intravenous folinic acid and pyridoxine therapy. Kidney Int 56, 2292-2296.
31. Ueland PM, Refsum H (1989). Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med 114, 473-501.
32. van Beynum I, den Heijer M, Thomas CM, Afman L, van Oppenraay ED, Blom HJ (2005). Total homocysteine and its predictors in Dutch children. Am J Clin Nutr 81, 1110-1116.
33. van Beynum I, Smeitink JA, den Heijer M, te Poele Pothoff MT, Blom HJ (1999). Hyperhomocysteinemia: a risk factor for ischemic stroke in children. Circulation 99, 2070-2072.
34. van der Linden I, Afman LA, Heil SG, Blom HJ (2006). Genetic variation in genes of folate metabolism and neural-tube defect risk. Proc Nutr Soc 65, 204-215.
35. van Oort FV, Melse-Boonstra A, Brouwer IA, Clarke R, West CE, Katan MB et al. (2003). Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study. Am J Clin Nutr 77, 1318-1323.
36. Verhoef P, de Groot LC (2005). Dietary determinants of plasma homocysteine concentrations. Semin Vasc Med 5, 110-123.
37. Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y et al. (2007). Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 369, 1876-1882.
38. Wilcken DE, Dudman NP, Tyrrell PA, Robertson MR (1988). Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease. Metabolism 37, 697-701.
39. Yango A, Shemin D, Hsu N, Jacques PF, Dworkin L, Selhub J et al. (2001). Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients. Kidney Int 59, 324-327.